New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
08:24 EDTTKMRTekmira Ebola drug could see emergency use in U.S., says Maxim
Maxim said the FDA's decision to change its full clinical hold on TKM-Ebola to a partial hold paves the way for potential emergency use of the drug in the U.S., if needed. Maxim noted that Tekmira's DOD contract for development of the treatment is initially worth $140M, adding that the firm expect Tekmira to receive a government supplier contract by 2018 for the drug. Maxim keeps its Buy rating and $23 price target on the stock.
News For TKMR From The Last 14 Days
Check below for free stories on TKMR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
15:02 EDTTKMRCongressman questions why FDA hasn't moved on Ebola drug, The Hill says
Republican Congressman Michael Burgess said he was "bewildered" as to why the FDA continues to have a hold on Tekmira's TKS-Ebloa drug, a treatment for Ebola, according to The Hill. However, Democratic Congresswoman Betty McCollum warned against using Africa as a "testing ground" for drugs that haven't been property screened, the website noted. Reference Link
September 11, 2014
10:20 EDTTKMRNebraska Medical Center not naming Ebola drug, The Street reports
Nebraska Medical Center is not releasing the name of the experimental Ebola drug being given to Dr. Rick Sacra, The Street's Adam Feuerstein reports, citing an emailed response from the hospital. Traders are speculating Tekmira (TKMR) is the manufacturer of the drug, Feuerstein points out. Sarepta (SRPT) disclosed that it is not involved in the treatment of Sacra, added Feuerstein. Shares of Tekmira are up 3% to $19.65 in morning trading. Reference Link
September 7, 2014
13:57 EDTTKMRGlaxoSmithKline Ebola vaccine works in tests on monkeys, Bloomberg says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use